Document Detail


Moderate exercise does not enhance the positive effect of estrogen on bone mineral density in postmenopausal women.
MedLine Citation:
PMID:  1834319     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We studied the effects of physical activity and two types of estrogen treatment in a prospective study in 78 healthy postmenopausal women. A control group and two treatment groups receiving estradiol valerate and medroxyprogesterone acetate in 1- or 3-month cycles were monitored for 1 year. Half of each group took part in an exercise program. Lumbar and femoral bone mineral density increased in both of the estrogen-treatment groups. Physical exercise with estrogen treatment did not result in further increases in bone mineral densities.
Authors:
J Heikkinen; E Kurttila-Matero; E Kyllönen; J Vuori; T Takala; H K Väänänen
Related Documents :
9681539 - Wrist arthroscopy for the treatment of ligament and triangular fibrocartilage complex i...
12729279 - Occurrence and persistence of perfluorooctanesulfonate and other perfluorinated surfact...
12544629 - Weight lifted in strength training predicts bone change in postmenopausal women.
2767409 - Photoperiodic time measurement during the termination of photorefractoriness in the sta...
11337129 - Effectiveness of a synthetic lure to reduce blowfly strike incidence: preliminary obser...
11532659 - Exercise in the prevention and treatment of osteoporosis: the role of physical therapy ...
18350779 - Chronotropic and neurohumoral markers for the evaluation of functional capacity in pati...
9238749 - A revised group exercise program for osteoarthritis of the knee.
15797849 - It's mine: initiating treatment success--my individualized nutrition and exercise plan.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Calcified tissue international     Volume:  49 Suppl     ISSN:  0171-967X     ISO Abbreviation:  Calcif. Tissue Int.     Publication Date:  1991  
Date Detail:
Created Date:  1991-11-26     Completed Date:  1991-11-26     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7905481     Medline TA:  Calcif Tissue Int     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S83-4     Citation Subset:  IM; S    
Affiliation:
Deaconess Institute of Oulu, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Density / drug effects*,  physiology
Estradiol / analogs & derivatives,  therapeutic use
Estradiol Congeners / therapeutic use*
Exercise / physiology*
Female
Humans
Medroxyprogesterone / analogs & derivatives,  therapeutic use
Medroxyprogesterone Acetate
Menopause
Middle Aged
Osteoporosis, Postmenopausal / prevention & control
Prospective Studies
Chemical
Reg. No./Substance:
0/Estradiol Congeners; 50-28-2/Estradiol; 520-85-4/Medroxyprogesterone; 71-58-9/Medroxyprogesterone Acetate; 979-32-8/estradiol valerate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A report on the feasibility of establishing a paediatric emergency dental service at Glasgow Dental ...
Next Document:  Biochemistry and genetics of Tay-Sachs disease.